Evidence map›Paper›PMID 32675241›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation.

Wendan Ren, Huitao Fan, Sara A Grimm, Yiran Guo, Jae Jin Kim, Jiekai Yin, Linhui Li, Christopher J Petell, Xiao-Feng Tan, Zhi-Min Zhang and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Epigenetic networks coordinate DNA methylation across the genome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 1 country.

Wendan RenDepartment of Biochemistry, University of California, Riverside, CA 92521.
Huitao FanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.ORCID 0000-0001-8250-3696
Sara A GrimmDivision of Intramural Research, Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Durham, NC 27709.
Yiran GuoLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.
Jae Jin KimDepartment of Molecular Biosciences, LIVESTRONG Cancer Institute of the Dell Medical School, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.
Jiekai YinEnvironmental Toxicology Graduate Program, University of California, Riverside, CA 92521.
Linhui LiDepartment of Biochemistry, University of California, Riverside, CA 92521.
Christopher J PetellLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.
Xiao-Feng TanDepartment of Biochemistry, University of California, Riverside, CA 92521.
Zhi-Min ZhangDepartment of Biochemistry, University of California, Riverside, CA 92521.
John P CoanDepartment of Biology, Stanford University, Stanford, CA 94305.
Linfeng GaoEnvironmental Toxicology Graduate Program, University of California, Riverside, CA 92521.
Ling CaiLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.
Brittany DetrickDepartment of Biochemistry, University of California, Riverside, CA 92521.
Burak ÇetinCell, Molecular, and Developmental Biology Graduate Program, University of California, Riverside, CA 92521.
Qiang CuiDepartment of Chemistry, Boston University, Boston, MA 02215.ORCID 0000-0001-6214-5211
Brian D StrahlLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.ORCID 0000-0002-4947-6259
Or GozaniDepartment of Biology, Stanford University, Stanford, CA 94305.
Yinsheng WangEnvironmental Toxicology Graduate Program, University of California, Riverside, CA 92521.
Kyle M MillerDepartment of Molecular Biosciences, LIVESTRONG Cancer Institute of the Dell Medical School, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-4544-0013
Seán E O'LearyDepartment of Biochemistry, University of California, Riverside, CA 92521.
Paul A WadeDivision of Intramural Research, Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Durham, NC 27709.
Dinshaw J PatelStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 pateld@mskcc.org greg_wang@med.unc.edu jikui.song@ucr.edu.ORCID 0000-0002-9779-7778
Gang Greg WangLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599; pateld@mskcc.org greg_wang@med.unc.edu jikui.song@ucr.edu.ORCID 0000-0002-7210-9940
Jikui SongDepartment of Biochemistry, University of California, Riverside, CA 92521; pateld@mskcc.org greg_wang@med.unc.edu jikui.song@ucr.edu.ORCID 0000-0002-4958-1032
University of California, Riverside · USUniversity of North Carolina at Chapel Hill · USLivestrong Foundation · USNational Institute of Environmental Health Sciences · USStanford University · USBoston University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Eukaryotic Transcriptional RegulationZIAES101965 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WADE, PAUL A · 2009 to 2025
$40.9M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Mechanisms of chromatin and transcriptional regulationR35GM126900 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian D Strahl · 2018 to 2026
$5.5M
Mechanistic Insights into Mammalian DNA MethylationR35GM119721 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Jikui Song · 2016 to 2026
$5.3M
Function of PHD Domain Proteins in Chromatin RegulationR01GM079641 · NIGMS · STANFORD UNIVERSITY · PI GOZANI, OR P. · 2007 to 2020
$4.5M
Eukaryotic Transcriptional RegulationZ01ES101965 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WADE, PAUL A · 2005 to 2008
$3.5M
Shaping DNA Damage Response Networks Via Histone H2A VariantsR01CA198279 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI Kyle M Miller · 2016 to 2026
$3.3M
Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple MyelomaR01CA211336 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, G GREG · 2017 to 2021
$2.0M
Mechanistic Insights into flavivirus NS5-mediated STAT2 SuppressionR01AI153419 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI HAI, RONG · 2021 to 2025
$1.9M
Intramural NIH HHS Z01 ES101965NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA198279NCI NIH HHS R01 CA201268NCI NIH HHS R01 CA210072NCI NIH HHS R01 CA211336NCI NIH HHS R01 CA215284NCI NIH HHS T32 CA009156NCI NIH HHS T32 CA009302NIAID NIH HHS R01 AI153419NIEHS NIH HHS R21 ES025392NIGMS NIH HHS R01 GM079641NIGMS NIH HHS R35 GM119721NIGMS NIH HHS R35 GM126900
6 · The paper itself

Abstract

In mammals, repressive histone modifications such as trimethylation of histone H3 Lys9 (H3K9me3), frequently coexist with DNA methylation, producing a more stable and silenced chromatin state. However, it remains elusive how these epigenetic modifications crosstalk. Here, through structural and biochemical characterizations, we identified the replication foci targeting sequence (RFTS) domain of maintenance DNA methyltransferase DNMT1, a module known to bind the ubiquitylated H3 (H3Ub), as a specific reader for H3K9me3/H3Ub, with the recognition mode distinct from the typical trimethyl-lysine reader. Disruption of the interaction between RFTS and the H3K9me3Ub affects the localization of DNMT1 in stem cells and profoundly impairs the global DNA methylation and genomic stability. Together, this study reveals a previously unappreciated pathway through which H3K9me3 directly reinforces DNMT1-mediated maintenance DNA methylation.

Indexed as

DNA MethylationDNA (Cytosine-5-)-Methyltransferase 1HeterochromatinHistonesHumansLysineMethylationProtein Processing, Post-TranslationalDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanHeterochromatinHistonesLysineallosteric regulationDNA methylationDNMT1H3K9me3

Identifiers

PMID32675241
PMCPMC7414182
OpenAlexW3042955551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.